Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Here’s what investors need to know.Mangoceuticals shares are powering higher. Why is MGRX stock surging?TRT Sales Surge 336%Since launching in mid-December, month-over-month sales for the injectable TRT program have climbed 336%, while customer acquisition costs have fallen 54%, the company said in an update. Management expects TRT to be the primary growth driver as MangoRx expands both injectable and oral options, including its PRIME capsule, powered by Kyzatrex.Telehealth Platform Targets Growing TRT Mark ...